Hyoscine Market Snapshot
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 4 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The Hyoscine Market is expected to register a CAGR of 4% during the forecast period attributing to effective medicine for motion sickness leading to a rise in consumer awareness towards hyoscine. Moreover, Motion sickness such as nausea, vomiting may cause by an increase in travelling which further led to the adoption of hyoscine medicines. For instance, According to National Library of Medicine (NIH) in 2018, Motion sickness is the common condition characterized by travelling or motion and frequency is one in three people are susceptible to this condition which leads to the rising demand of hyoscine. Furthermore, growth in a number of surgeries supplement is also one of the factors boosting the hyoscine market attributing to use in surgeries for controlling and decreasing saliva content and gastric acid, to slow gut motility and prevent vomiting. Moreover, the rise in usage of transdermal hyoscine patches in surgeries & post-operative recovery and a rise in emphasis on community healthcare in developing countries is expected to provide a lucrative opportunity in developing countries. However, stringent regulation related to the manufacturing and marketing of hyoscine products may hamper the market to a certain extent.
Scope of the Report
Hyoscine is an effective medicine for motion sickness and used to treat postoperative nausea, gastrointestinal spasm, and vomiting. This medicine belongs to the antimuscarinic family and works by blocking some acetylcholine effects within the nervous system.
| By Type | |
| Hyoscine Butylbromide | |
| Hyoscine Hydrobromide |
| By Mode of Administration | |
| Oral | |
| Patches | |
| Injections |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Key Market Trends
Oral Hyoscine is Expected to Hold a Major Market Share in the Hyoscine Market
Oral hyoscine is expected to contribute the largest segment attributing to ease of administration, easy availability and wide preference in abdominal muscle cramp and treating motion sickness. Oral tablets compared to patches and injection will not need prescriptions and can easily available in pharmacies, leading to low health care costs and further drive the oral segment. Moreover increased patient pool and increase in travelling population is leading to a high demand of hyoscine and propel the growth of oral hyoscine market.
To understand key trends, Download Sample Report
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a significant market share in the global Hyoscine market owing to many market players operating in manufacturing the medicines, growth in number of surgeries supplements, growing healthcare concern, increasing healthcare expenditure and presence of well-established healthcare infrastructure.
To understand geography trends, Download Sample Report
Competitive Landscape
The market studied is moderately competitive and there are several international and local companies operating in this market. Some of the companies which are in the market are Caleb Pharmaceuticals, Inc, Baxter International, Alkaloids Corporation., Alchem International Pvt. Ltd, Guangzhou HanFang Pharmaceutical, MYUNGMOON PHARM CO., LTD., and Perrigo.
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rise in Consumer Awareness Towards Hyoscine
-
4.2.2 Increase in Travelling
-
-
4.3 Market Restraints
-
4.3.1 Regulatory Framework
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type
-
5.1.1 Hyoscine Butylbromide
-
5.1.2 Hyoscine Hydrobromide
-
-
5.2 By Mode of Administration
-
5.2.1 Oral
-
5.2.2 Patches
-
5.2.3 Injections
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Caleb Pharmaceuticals, Inc
-
6.1.2 Baxter International
-
6.1.3 Alkaloids Corporation.
-
6.1.4 Alchem International Pvt. Ltd
-
6.1.5 Guangzhou HanFang Pharmaceutical
-
6.1.6 MYUNGMOON PHARM CO.,LTD.
-
6.1.7 Perrigo
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Hyoscine Market market is studied from 2018 - 2026.
What is the growth rate of Hyoscine Market?
The Hyoscine Market is growing at a CAGR of 4% over the next 5 years.
Which region has highest growth rate in Hyoscine Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Hyoscine Market?
North America holds highest share in 2021.
Who are the key players in Hyoscine Market?
Caleb Pharmaceuticals, Inc, Baxter International, Alkaloids Corporation, Alchem International Pvt. Ltd, Guangzhou HanFang Pharmaceutical are the major companies operating in Hyoscine Market.
